Modified atherogenic lipoproteins induce expression of pentraxin-3 by human vascular smooth muscle cells
- 1 August 2004
- journal article
- Published by Elsevier BV in Atherosclerosis
- Vol. 175 (2), 221-228
- https://doi.org/10.1016/j.atherosclerosis.2004.03.020
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Enzymatically Modified Nonoxidized Low-Density Lipoprotein Induces Interleukin-8 in Human Endothelial CellsCirculation, 2002
- Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune responseNature, 2002
- Long Pentraxin PTX3 Upregulates Tissue Factor Expression in Human Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Risk of Myocardial Infarction and Angina in Patients With Severe Peripheral Vascular DiseaseCell Metabolism, 2002
- Complement and AtherogenesisArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Enzymatically Modified, Nonoxidized LDL Induces Selective Adhesion and Transmigration of Monocytes and T-Lymphocytes Through Human Endothelial Cell MonolayersArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Atherogenic Properties of Enzymatically Degraded LDLArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Immunohistochemical Demonstration of Enzymatically Modified Human LDL and Its Colocalization With the Terminal Complement Complex in the Early Atherosclerotic LesionArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- gp130 AND THE INTERLEUKIN-6 FAMILY OF CYTOKINESAnnual Review of Immunology, 1997
- Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994